浙江医药涨2.05%，成交额2.02亿元，主力资金净流入507.51万元

Core Viewpoint - Zhejiang Medicine's stock price increased by 2.05% on November 7, reaching 14.93 CNY per share, with a total market capitalization of 14.357 billion CNY [1] Financial Performance - For the period from January to September 2025, Zhejiang Medicine reported operating revenue of 6.695 billion CNY, a year-on-year decrease of 5.87%, while net profit attributable to shareholders increased by 9.83% to 933 million CNY [2] - Cumulative cash dividends since the company's A-share listing amount to 4.377 billion CNY, with 661 million CNY distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 3.83% to 63,000, while the average circulating shares per person increased by 3.98% to 15,258 shares [2] - The third-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 46.6455 million shares, a decrease of 24.6449 million shares from the previous period [3]